Retraction Notice: Enhanced Release Kinetics and Stability of Resveratrol Loaded Self Nanoemulsifying Delivery Systems Developed using Experimental Design

Author(s): Monika Sharma*

Journal Name: Current Nanomedicine
Formerly Recent Patents on Nanomedicine

Volume 9 , Issue 2 , 2019

Become EABM
Become Reviewer

Abstract:

The article has been withdrawn from the journal “Current Nanomedicine” as it has already been found to be published in the journal “International Journal of Pharmaceutical Sciences and Research”.

Bentham Science apologizes to its readers for any inconvenience this may have caused.

The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policiesmain. php.

Bentham Science Disclaimer:

It is a condition of publishers that manuscripts submitted to this journal should not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and while submit- ting the article for publication, the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers, if and when the article is accepted for publication.

[1]
Qian J, Meng H, Xin L, et al. Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation. Colloids Surf B Biointerfaces 2017; 160: 101-9.
[2]
Singh B, Garg B, Kaur R, Jain A, Kumar R, Prakash Om. Self-nanoemulsifying systems for oral bioavailability enhancement. Fabrication and Self-Assembly of Nanobiomaterials 2017; pp. 91-115.
[3]
Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 2010; 391: 203-11.
[4]
Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev 2001; 50: 61-80.
[5]
AboulFotouh K. Allam AA, El-Badry M, El-Sayed AM. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil. Eur J Pharm Sci 2017; 15(109): 503-13.
[6]
Irina C, Abraham JD, Amnon H. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin Drug Deliv 2015; 12(7): 1121-33.
[7]
Jeevana JB, Sreelakshmi K. Design and evaluation of selfnanoemulsifying drug delivery system of flutamide. J Young Pharm 2011; 3: 4-8.
[8]
Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007; 6: 231-48.
[9]
Bandyopadhyay S, Katare OP, Singh B. Optimized self-nanoemulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces 2012; 100: 50-61.
[10]
Nielsen FS, Petersen KB, Müllertz A. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm 2008; 69: 553-62.
[11]
Amri A, Chaumeil JC, Sfar S, Charrueau C. Administration of resveratrol: What formulation solutions to bioavailability limitations? J Control Release 2012; 158: 182-93.
[12]
Pangeni R. Jasjeet Sahni, Javed Ali K, Sharma S. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Informa Healthcare 2014; 11(8): 1285-98.
[13]
Donatella P, Maria PF, Fatima A, et al. Resveratrol (trans-3,5,4-trihydroxystilbene; RSV) and its properties in oral disease. Exp Thera. Med 2017; 14(1): 3-9.
[14]
Monika Garg R, Sardana S. Research Problems Associated with Resveratrol (trans-3,5,4-trihydroxystilbene; RSV) and Various Strategies to Overcome those Problems. Curr Drug Deliv 2017; 14(3): 364-76.
[15]
Caymanchem, assessed on 2014. Available from; https://www.caymanchem.com/pdfs/70675.pdf-CAS510-36-0.
[16]
Marier JF, Vachon P, Gritsas A. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002; 302: 369-73.
[17]
Singh G, Pai RS. Pharmacokinetics and in vivo bio distribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine. Drug Deliv 2013; 23(9): 3209-23.
[18]
Singh G, Pai RS. Trans-resveratrol self-nanoemulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv 2015; 22(4): 522-30.
[19]
Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-impact of different polymers. J Pharm Sci 2013; 102: 171-84.
[20]
Troche-Pesqueira E, Perez-Juste I, Navarro-Vazquez A. Cid. MM. A b-cyclodextrin-resveratrol inclusion complex and the role of geometrical and electronic effects on its electronic induced circular dichroism. RSC Advances 2013; 3: 10242-50.
[21]
Gehan F, Naser A, Mohamad AS, et al. Resveratrol β-cyclodextrin/lecithin complexes: A new approach for treatment of hepatic dysfunction. J Pharm Pharm Sci 2017; 6(1): 1-15.
[22]
Bandyopadhyay S, Katare O, Singh B. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv 2014; 11: 479-92.
[23]
Azeem A, Rizwan MF, Ahmad J. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 2009; 10(1): 69-76.
[24]
Singh G, Pai RS, Devi VK. Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design. J Adv Pharm Technol Res 2012; 3: 30-40. a
[25]
Dash RN, Mohammed H, Humaira T. Design, optimization, and evaluation of ezetimibe solid supersaturatable self-nanoemulsifying drug delivery for enhanced solubility and dissolution. Journal of Pharmaceutical Investigation 2016; 46(2): 153-68.
[26]
Patel G, Shelat P, Lalwani A. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment. Drug Deliv 2016; 23(8): 3027-42.
[27]
Khan AW, Kotta S, Ansari SH, Sharma RK, Ali A. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation. Drug Deliv 2015; 22(4): 552-61.
[28]
Puri R, Mahajan M, Sahajpal NS, Singh H, Singh H, Jain SK. Self-nanoemulsifying drug delivery system of docosahexanoic acid: development, in vitro- in vivo characterization. Drug Dev Ind Pharm 2016; 42(7): 1032-41.
[29]
Soltani Y, Goodarzi N, Mahjub R. Preparation and characterization of self nano-emulsifying drug delivery system (SNEDDS) for oral delivery of heparin using hydrophobic complexation by cationic polymer of β-cyclodextrin. Drug Dev Ind Pharm 2017; 43(11): 1899-907.
[30]
Barzegar-Jalali M, Adbika K, Valizadeh H, et al. Kinetic analysis of drug release from nanoparticles. J Pharm Sci 2008; 11(1): 167-77.
[31]
Swenson ES, Milisen WB, Curatolo W. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res 1994; 11: 1132-42.
[32]
Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A Physicochem Eng Asp 2011; 392: 145-55.


promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 9
ISSUE: 2
Year: 2019
Published on: 20 August, 2019
Page: [128 - 145]
Pages: 18
DOI: 10.2174/2468187308666180613104123

Article Metrics

PDF: 42
HTML: 4